Global and United States Neurological Biomarkers Market

Global and United States Neurological Biomarkers Market Report & Forecast 2024-2030

Global and United States Neurological Biomarkers Market

Global and United States Neurological Biomarkers Market Report & Forecast 2024-2030


The research report on ‘Neurological Biomarkers Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

The research time span covered by the report is from 2019 to 2030; it provides an overview of the Global Neurological Biomarkers Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.

The global Neurological Biomarkers market size in 2023 is 6921.5 million US dollars, and it is expected to be 16568.2 million US dollars by 2030, with a compound annual growth rate of 13.28% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:

The main players in the Neurological Biomarkers market include Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), McKesson Corporation (U.S), and R1 RCM Inc., (U.S). The share of the top 3 players in the Neurological Biomarkers market is XX%.

REGION SHARE:

The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Neurological Biomarkers market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:

The report segments the market by Type and Application. Genomics Biomarker accounted for XX% of Neurological Biomarkers market in 2023. Proteomics Biomarker share of XX%.

Clinical Diagnostics accounted for XX% of the Neurological Biomarkers market in 2023. Pharmaceutical And Biotechnology Companies accounts for XX%.

For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.

As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.

Key Factors Considered:

COVID-19

The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.

Regional Conflict / Russia-Ukraine War

The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.

Challenges & Opportunities

Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.

Chapter Outline

Chapter 1: Introduces the product overview, market scope, study objectives, and industry dynamic analysis, and then includes the global impact of the coronavirus disease (COVID-19).

Chapter 2: Analysis of the competitive environment of Neurological Biomarkers market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the players' M&A and expansion in recent years.

Chapters 3-6: Segmented the global Neurological Biomarkers market by type, application and region. Analyze the revenue of market segments from different perspectives.

Chapter 7: Analyzes the main companies in the Neurological Biomarkers industry, including their main businesses, products/services, sales, revenue, gross margin, and the latest developments.

Chapter 8: Analyzes the Neurological Biomarkers industry chain, including raw material analysis, sales and marketing, distributors and major downstream buyers.

Chapter 9: The main points and conclusions of the report.

Chapter 10: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Latin America

Brazil

Argentina

Mexico

MEA

Saudi Arabia

UAE

Turkey

Player list

Thermo Fisher Scientific (U.S.)

QIAGEN (Netherlands)

Agilent Technologies, Inc. (U.S.)

McKesson Corporation (U.S)

R1 RCM Inc., (U.S)

F. Hoffmann-La Roche Ltd. (Switzerland)

Bio-Rad Laboratories, Inc. (U.S.)

BGI (China), Quanterix (U.S.)

bioMérieux Inc (U.S.)

Neurosteer Inc. (U.S.)

Advanced Brain Monitoring, Inc (U.S.)

Types list

Genomics Biomarker

Proteomics Biomarker

Imaging Biomarker

Metabolomics Biomarker

Others

Application list

Clinical Diagnostics

Pharmaceutical And Biotechnology Companies

Research Organizations

Table of Content

1 Study Coverage

1.1 Neurological Biomarkers Product Introduction

1.2 Global Neurological Biomarkers Outlook 2019 VS 2024 VS 2030

1.3 United States Neurological Biomarkers Outlook 2019 VS 2024 VS 2030

1.4 Neurological Biomarkers Market Size, United States VS Global, 2019-2030

1.4.1 The Market Share of United States Neurological Biomarkers in Global, 2019-2030

1.4.2 The Growth Rate of Neurological Biomarkers Market Size, United States VS Global, 2019 VS 2024 VS 2030

1.5 Neurological Biomarkers Market Dynamics

1.5.1 Neurological Biomarkers Market Trends

1.5.2 Neurological Biomarkers Market Drivers

1.5.3 Neurological Biomarkers Market Challenges

1.5.4 Neurological Biomarkers Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Coronavirus Disease (COVID-19) Impact on Global

2 Global Neurological Biomarkers Competitor Landscape by Company

2.1 Global Neurological Biomarkers Market Size by Company

2.1.1 Top Global Neurological Biomarkers Player Ranked by Revenue (2024)

2.1.2 Global Neurological Biomarkers Revenue by Player (2019-2024)

2.2 Global Neurological Biomarkers Concentration Ratio (CR)

2.2.1 Neurological Biomarkers Market Concentration Ratio (CR) (2019-2024)

2.2.2 Global Top 3 and Top 6 Largest Players of Neurological Biomarkers in 2024

2.3 Global Neurological Biomarkers Business Distribution, Business Type

2.3.1 Global Neurological Biomarkers Players, Headquarters and Distribution

2.3.2 Players Neurological Biomarkers Business Type

2.3.3 Date of International Players Enter into Neurological Biomarkers Market

2.4 Players Mergers & Acquisitions, Expansion Plans

2.5 United States Neurological Biomarkers Market Size by Company

2.5.1 Top United States Neurological Biomarkers Player s Ranked by Revenue (2024)

2.5.2 United States Neurological Biomarkers Revenue by Player (2019-2024)

3 Neurological Biomarkers Market Segment by Type

3.1 Neurological Biomarkers Market Segment by Type

3.2 Global Neurological Biomarkers Market Size by Type

3.3 United States Neurological Biomarkers Market Size by Type

4 Neurological Biomarkers Market Segment by Application

4.1 Neurological Biomarkers Market Segment by Application

4.2 Global Neurological Biomarkers Market Size by Application

4.3 United States Neurological Biomarkers Market Size by Application

5 Global Neurological Biomarkers Market Size by Region

5.1 Global Neurological Biomarkers Market Size by Region: 2019 VS 2024 VS 2030

5.2 Global Neurological Biomarkers Market Size in Value by Region (2019-2030)

5.2.1 Global Neurological Biomarkers Revenue by Region: 2019-2024

5.2.2 Global Neurological Biomarkers Revenue by Region: 2024-2030

5.3 Global Neurological Biomarkers Market Size in Volume by Region (2019-2030)

5.3.1 Global Neurological Biomarkers Volume by Region: 2019-2024

5.3.2 Global Neurological Biomarkers Volume by Region: 2024-2030

6 Segment in Regional Level & Country Level

6.1 North America

6.1.1 North America Neurological Biomarkers Market Size YoY Growth 2019-2030

6.1.2 North America Neurological Biomarkers Market Facts & Figures by Country (2019-2030)

6.1.3 U.S.

6.1.4 Canada

6.2 Asia Pacific

6.2.1 Asia Pacific Neurological Biomarkers Market Size YoY Growth 2019-2030

6.2.2 Asia Pacific Neurological Biomarkers Market Facts & Figures by Country (2019-2030)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 Southeast Asia

6.3 Europe

6.3.1 Europe Neurological Biomarkers Market Size YoY Growth 2019-2030

6.3.2 Europe Neurological Biomarkers Market Facts & Figures by Country (2019-2030)

6.3.3 Germany

6.3.4 France

6.3.5 UK

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Neurological Biomarkers Market Size YoY Growth 2019-2030

6.4.2 Latin America Neurological Biomarkers Market Facts & Figures by Country (2019-2030)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Neurological Biomarkers Market Size YoY Growth 2019-2030

6.5.2 Middle East and Africa Neurological Biomarkers Market Facts & Figures by Country (2019-2030)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

7.1 Thermo Fisher Scientific (U.S.)

7.1.1 Thermo Fisher Scientific (U.S.) Company Details

7.1.2 Description and Business Overview

7.1.3 Neurological Biomarkers Introduction

7.1.4 Thermo Fisher Scientific (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.1.5 Thermo Fisher Scientific (U.S.) Recent Development

7.2 QIAGEN (Netherlands)

7.2.1 QIAGEN (Netherlands) Company Details

7.2.2 Description and Business Overview

7.2.3 Neurological Biomarkers Introduction

7.2.4 QIAGEN (Netherlands) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.2.5 QIAGEN (Netherlands) Recent Development

7.3 Agilent Technologies, Inc. (U.S.)

7.3.1 Agilent Technologies, Inc. (U.S.) Company Details

7.3.2 Description and Business Overview

7.3.3 Neurological Biomarkers Introduction

7.3.4 Agilent Technologies, Inc. (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.3.5 Agilent Technologies, Inc. (U.S.) Recent Development

7.4 McKesson Corporation (U.S)

7.4.1 McKesson Corporation (U.S) Company Details

7.4.2 Description and Business Overview

7.4.3 Neurological Biomarkers Introduction

7.4.4 McKesson Corporation (U.S) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.4.5 McKesson Corporation (U.S) Recent Development

7.5 R1 RCM Inc., (U.S)

7.5.1 R1 RCM Inc., (U.S) Company Details

7.5.2 Description and Business Overview

7.5.3 Neurological Biomarkers Introduction

7.5.4 R1 RCM Inc., (U.S) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.5.5 R1 RCM Inc., (U.S) Recent Development

7.6 F. Hoffmann-La Roche Ltd. (Switzerland)

7.6.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Details

7.6.2 Description and Business Overview

7.6.3 Neurological Biomarkers Introduction

7.6.4 F. Hoffmann-La Roche Ltd. (Switzerland) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.6.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development

7.7 Bio-Rad Laboratories, Inc. (U.S.)

7.7.1 Bio-Rad Laboratories, Inc. (U.S.) Company Details

7.7.2 Description and Business Overview

7.7.3 Neurological Biomarkers Introduction

7.7.4 Bio-Rad Laboratories, Inc. (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.7.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Development

7.8 BGI (China), Quanterix (U.S.)

7.8.1 BGI (China), Quanterix (U.S.) Company Details

7.8.2 Description and Business Overview

7.8.3 Neurological Biomarkers Introduction

7.8.4 BGI (China), Quanterix (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.8.5 BGI (China), Quanterix (U.S.) Recent Development

7.9 bioMérieux Inc (U.S.)

7.9.1 bioMérieux Inc (U.S.) Company Details

7.9.2 Description and Business Overview

7.9.3 Neurological Biomarkers Introduction

7.9.4 bioMérieux Inc (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.9.5 bioMérieux Inc (U.S.) Recent Development

7.10 Neurosteer Inc. (U.S.)

7.10.1 Neurosteer Inc. (U.S.) Company Details

7.10.2 Description and Business Overview

7.10.3 Neurological Biomarkers Introduction

7.10.4 Neurosteer Inc. (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.10.5 Neurosteer Inc. (U.S.) Recent Development

7.11 Advanced Brain Monitoring, Inc (U.S.)

7.11.1 Advanced Brain Monitoring, Inc (U.S.) Company Details

7.11.2 Description and Business Overview

7.11.3 Neurological Biomarkers Introduction

7.11.4 Advanced Brain Monitoring, Inc (U.S.) Neurological Biomarkers Revenue, Sales, and Gross Margin (2019-2024)

7.11.5 Advanced Brain Monitoring, Inc (U.S.) Recent Development

8 Industry Chain and Sales Channels Analysis

8.1 Neurological Biomarkers Value Chain Analysis

8.2 Neurological Biomarkers Key Raw Materials

8.2.1 Key Raw Materials

8.2.2 Distributors List

8.3 Neurological Biomarkers Production Mode & Process

8.4 Neurological Biomarkers Sales and Marketing

8.4.1 Magnetic Coupled Mixers Sales Channels

8.4.2 Magnetic Coupled Mixers Distributors

8.5 Magnetic Coupled Mixers Customers

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 A Methodology

10.1.1 Research Process

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 B Data Source

10.2.1 Legal Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Neurological Biomarkers Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
How are players chosen for the research coverage of the Neurological Biomarkers Market study?
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
What are the major applications for Neurological Biomarkers ?
Neurological Biomarkers has a wide range of applications, including and others.
What is the forecasted growth rate of the Neurological Biomarkers Market?
The Neurological Biomarkers Market is expected to grow at a moderate CAGR during the forecast period of 2025 to 2030.
What is really changing the Neurological Biomarkers Market behavior?
Consumer behavior changes will reshape the entire decision-making process and companies in the Neurological Biomarkers Industry will need to adapt quickly.
How does the Neurological Biomarkers Market study reflects the current scenario?
The Neurological Biomarkers study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.